share_log

苑东生物(688513.SH):贝前列素钠片获得药品注册证书

Yuandong Biology (688513.SH): Beprost sodium tablets obtained drug registration certificate

Gelonghui Finance ·  May 21 06:13

Gelonghui, May 21丨Yuandong Biology (688513.SH) announced that the company recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration. The main component of beprost sodium tablets is beprost sodium. The indication is to improve symptoms such as ulcers, intermittent claudication, pain, and cold sensation caused by chronic arterial occlusive disease.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment